Ursa Sapiens
  • The Blog
  • Team
  • About Us
  • Categories
  • Blog Archives
    • December 2014
    • November 2014
    • April 2014
    • March 2014
    • February 2014
    • January 2014
    • December 2013
  • Brown TTH

Just Hit Print: The Rise of 3D Bioprinting and the Future of Medicine (Part 3/3)

12/10/2013

4 Comments

 
by Jennifer Maccani, PhD

This is part 3 of a 3-part article.  This article is part of the "Emerging Biotechnology" series.
It all began in 2008. That was the year Organovo Holdings, Inc. founder Dr. Gabor Forgacs of the University of Missouri–Columbia published an article in the journal Tissue Engineering Part A describing the first ever bioprinted blood vessel construct from chicken cells (15, 16).

Rather than growing cells in a flat layer covered by cell culture media with the nutrients necessary for the cells’ survival, Dr. Forgacs and his colleagues had printed cells, or “bio-ink,” and collagen scaffolding (“bio-paper”) into a living three-dimensional structure (15). The beauty of his approach was that in a three-dimensional environment, the cells were free to do what their DNA programmed them to do—fuse with their neighbors and behave as they would in the body. This process of “self-assembly,” Dr. Forgacs explains, allows cells to retain their natural shape and characteristics that can sometimes be lost in the context of traditional two-dimensional cell culturing, such as in a petri dish (15). In the case of the chicken blood vessel constructs, the cells began to contract and “beat” (15)—just like a heart (16).
If you’re still imagining the plight of the patient with heart failure, that’s good news—very good news. And it gets better.
If that hadn’t gotten the attention of the medical community, Organovo’s current projects certainly have. Since Organovo developed the first commercial 3D bioprinter in 2009, the company has partnered with pharmaceutical companies such as Pfizer (17) as well as research institutions like Harvard Medical School (18), with the hope that Organovo’s 3D NovoGen™ MMX bioprinter (19) can be used in drug development and disease and regenerative medicine research.
PictureA cross-section of bioprinted liver. [image via]
In April 2013, Organovo presented findings at the Experimental Biology conference in Boston, (19-21) describing a bioprinted liver model (21, 22). The liver model was made up of multiple cell types deposited in their natural architecture, capable of performing normal functions required of liver tissue—it produced proteins including albumin and fibrinogen, could be induced to secrete enzymes like the drug-metabolizing CYP1A2, and biosynthesized cholesterol. Basically, the model works just like liver tissue in the human body (21, 22). By demonstrating superior functionality, Organovo has set the stage for a revolutionary approach to testing new pharmaceuticals (20, 21), particularly in the wake of an article published in early 2013 in the Proceedings of the National Academy of Sciences by Dr. H. Shaw Warren and colleagues calling the accuracy and appropriateness of the use of animal models to research human diseases like sepsis into question (23, 24). As reported in The New York Times, independent medical experts have said that the article may change the course of such research (23).

As an emerging technology with a myriad of potential clinical applications, 3D bioprinting is already improving the quality of care for dental patients and those in need of prosthetic limbs (25). Using 3D bioprinting, dental laboratories can take digital scans of patients’ teeth that can then be used to manufacture dental crowns, bridges, and implants, eliminating the need to take less accurate, uncomfortable molds while at the same time increasing affordability (25). In the field of prosthetics, 3D bioprinting has brought personalization and human dignity to patients needing prosthetic limbs, helping doctors to create leg prosthetics, for example, closely matching a patient’s remaining leg (25).

However, there are hurdles the technology must overcome before it can advance into other applications. One potential issue with 3D bioprinting technology is long-term viability of bioprinted tissues. Without normal vasculature, cells lack the oxygen and other materials necessary for growth and differentiation—akin to suffocation (26). However, researchers at the University of Pennsylvania have published an article in Nature Materials last year that may solve that problem (27). Their approach consists of 3D-printed vascular templates made of sugar that dissolve once cells are added. Once the sugar mixture of sucrose, glucose, and dextran has flowed out through the channels left behind, fluid can flow through the bioprinted tissue.

Bioprinting technology has the potential to improve clinical care and revolutionize human disease research, and may be a powerful tool for the advancement of both bedside medical practice as well as scientific pursuits at the bench. The future of 3D bioprinting and those who may benefit from it, not to mention the future of additive manufacturing in general, looks bright.

As for Tyler Benster and his colleagues at Azavy? “In the fall we’re looking at a couple of different startup incubators including Betaspring… in the fall we would also start looking at raising a seed round of capital,” Benster says of his plans, in which he will work full-time at the company. If it’s successful, Azavy will help to connect designers and potential users to 3D printing resources, an endeavor that will have far-reaching benefits, even extending to ground-breaking medical and scientific advances. 

3D printing has already had a positive impact on Cosima Schunk’s scientific research. “[3D printing] made the research as I’m doing it possible,” Schunk says. “We are scientists; we want to learn how a bat is flying and what we can learn from it, and that’s our major motivation.” When asked how 3D printing has allowed her to answer a research question she otherwise could not have, Schunk admits, “I could not think of an easy way how we would do it without a 3D printer.”

In the end, the rise of 3D printing, especially its scientific and medical applications via 3D bioprinting, may sow a revolution-in-the-making within our own lifetimes—lifetimes that, if you’re a heart transplant patient, might be a lot longer, thanks to 3D bioprinting.

  1. Jakab K, Norotte C, Damon B, Marga F, Neagu A, Besch-Williford CL, et al. Tissue engineering by self-assembly of cells printed into topologically defined structures. Tissue engineering Part A. 2008;14(3):413-21. Epub 2008/03/13.
  2. Marris E. How to print out a blood vessel. Nature; 2008 [updated 20 Mar 2008; cited 2013 July 3]; Available from: http://www.nature.com/news/2008/080320/full/news.2008.675.html
  3. Napodano J. Checking In On Organovo. SeekingAlpha.com; 2013 [updated Mar 20, 2013; cited 2013 July 3]; Available from: http://seekingalpha.com/article/1288701-checking-in-on-organovo
  4. Holmes D. Organovo CEO Keith Murphy Is Refilling The Cartridge For Printing Human Organs. Fast Company; 2012 [updated Apr 2, 2012; cited 2013 July 3]; Available from: http://www.fastcompany.com/1826458/organovo-ceo-keith- murphy-refilling-cartridge-printing-human-organs
  5. Organovo Holdings Inc. 3D Human Tissues for Research. Organovo.com; 2013 [updated 2013; cited 2013 July 3]; Available from: http://www.organovo.com/3d-human-tissues/3d-human-tissues-research
  6. Napodano J. Organovo's Breakthrough In Hepatotoxicity Testing. SeekingAlpha.com; 2013 [updated Jun 3, 2013; cited 2013 July 3]; Available from: http://seekingalpha.com/article/1477191-organovo-s-breakthrough-in-hepatotoxicity-testing
  7. PRNewswire. Organovo Describes First Fully Cellular 3D Bioprinted Liver Tissue. Organovo.com; 2013 [updated April 22, 2013; cited 2013 July 3]; Available from: http://ir.organovo.com/news/press-releases/press-releases-details/2013/Organovo-Describes-First-Fully-Cellular-3D-Bioprinted-Liver-Tissue/default.aspx
  8. Organovo Holdings Inc. 3D Human Liver Tissue Model. Organovo.com; 2013 [updated 2013; cited 2013 July 3]; Available from: http://www.organovo.com/3d-human-tissues/3d-human-tissues-research/tissue-models/3d-human-liver-tissue-model
  9. Kolata G. Mice Fall Short as Test Subjects for Some of Humans' Deadly Ills. The New York Times; 2013 [updated Feb 11, 2013; cited 2013 July 3]; Available from: http://www.nytimes.com/2013/02/12/science/testing-of-some-deadly-diseases-on-mice-mislead-report-says.html?pagewanted=all&_r=0
  10. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(9):3507-12. Epub 2013/02/13.
  11. Banham R. Printing a Medical Revolution. T. Rowe Price; 2012 [updated May 2012; cited 2013 July 3]; Available from: http://individual.troweprice.com/public/Retail/Planning-&-Research/Connections/3D-Printing/Printing-a-Medical-Revolution
  12. Lerner E. Penn Researchers Improve Living Tissues With 3D Printed Vascular Networks Made From Sugar. PennNews; 2012 [updated July 1, 2012; cited 2013 July 3]; Available from: http://www.upenn.edu/pennnews/news/penn-researchers-improve-living-tissues-3d-printed-vascular-networks-made-sugar
  13. Miller JS, Stevens KR, Yang MT, Baker BM, Nguyen DH, Cohen DM, et al. Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues. Nature materials. 2012;11(9):768-74. Epub 2012/07/04.
4 Comments
Raghav Kulkarni link
4/18/2022 04:40:10 am

Great article on 3D printing and its applications in Medical field. I have also written a article on how 3D printing industry can be used in Medical field. I hope you like it !

https://crowdkonnect.com/3d-printing-in-medical-industry/

Reply
Alice link
6/2/2022 06:01:24 am

Hey

Just wanted to quickly pitch you a piece of content for consideration in your blogs.

keep me posted

I am happy to push it out to my email list and social fans!

Best regards

Alice: https://zetarmold.com

Reply
Alice link
6/2/2022 06:00:31 am

Hello

I was searching for some articles about 3D printing today and I came across this page:

I am a novice in the manufacturing industry and am learning the knowledge of the injection molding industry. I noticed that you linked to one of my favorite articles. Find this article very helpful.

Anyway, keep trying, thanks again for your insights!

Best regards

Alice: https://zetarmold.com

Reply
Jane link
12/6/2022 09:07:37 am

Thank you very much for your analysis. Our company is also engaged in related industries and your article is very helpful to us. Our company's website is https://zetarindustry.com
We are looking forward to the publication of your article soon and it will inspire us more.

Reply



Leave a Reply.

Powered by Create your own unique website with customizable templates.
  • The Blog
  • Team
  • About Us
  • Categories
  • Blog Archives
    • December 2014
    • November 2014
    • April 2014
    • March 2014
    • February 2014
    • January 2014
    • December 2013
  • Brown TTH